Inspire Medical Systems Gross Profit 2017-2024 | INSP
Inspire Medical Systems annual/quarterly gross profit history and growth rate from 2017 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Inspire Medical Systems gross profit for the quarter ending September 30, 2024 was $0.171B, a 32.48% increase year-over-year.
- Inspire Medical Systems gross profit for the twelve months ending September 30, 2024 was $0.641B, a 33.58% increase year-over-year.
- Inspire Medical Systems annual gross profit for 2023 was $0.528B, a 54.57% increase from 2022.
- Inspire Medical Systems annual gross profit for 2022 was $0.342B, a 70.77% increase from 2021.
- Inspire Medical Systems annual gross profit for 2021 was $0.2B, a 104.7% increase from 2020.
| Inspire Medical Systems Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $528 |
| 2022 | $342 |
| 2021 | $200 |
| 2020 | $98 |
| 2019 | $68 |
| 2018 | $41 |
| 2017 | $23 |
| 2016 | $13 |
| Inspire Medical Systems Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $171 |
| 2024-06-30 | $166 |
| 2024-03-31 | $139 |
| 2023-12-31 | $164 |
| 2023-09-30 | $129 |
| 2023-06-30 | $127 |
| 2023-03-31 | $108 |
| 2022-12-31 | $116 |
| 2022-09-30 | $89 |
| 2022-06-30 | $77 |
| 2022-03-31 | $59 |
| 2021-12-31 | $67 |
| 2021-09-30 | $53 |
| 2021-06-30 | $45 |
| 2021-03-31 | $34 |
| 2020-12-31 | $39 |
| 2020-09-30 | $31 |
| 2020-06-30 | $10 |
| 2020-03-31 | $18 |
| 2019-12-31 | $23 |
| 2019-09-30 | $17 |
| 2019-06-30 | $15 |
| 2019-03-31 | $13 |
| 2018-12-31 | $13 |
| 2018-09-30 | $11 |
| 2018-06-30 | $9 |
| 2018-03-31 | $8 |
| 2017-12-31 | $8 |
| 2017-09-30 | $6 |
| 2017-06-30 | $5 |
| 2017-03-31 | $4 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.055B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |